iShares Neuroscience and Healthcare ETF

IBRN · ETF

$31.36−$0.3839 (−1.21%)TodayMarket closed ·
Prev close $31.75

About IBRN

IBRN was created on 2022-08-24 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 6.27m in AUM and 69 holdings. IBRN tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.

Issuer
iShares
Tracks
NYSE FactSet Global Neuro Biopharma and MedTech Index
Expense ratio
0.47%
Assets under management
$6.30M
Inception
Aug 24, 2022
Asset class
Equity

IBRN key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
1.43K
Volume
317
Open price
$31.69
High today
$31.69
Low today
$31.19
52 Week high
$43.01
52 Week low
$27.70

iShares Neuroscience and Healthcare ETF (IBRN) at a glance

iShares Neuroscience and Healthcare ETF (IBRN) last traded at $31.36, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $31.19 and $31.69. The current price is 0.6% above the day's low and 1.0% below its high.

Volume so far is 317 shares, below the average of 1.43K shares a day.

Over the past year iShares Neuroscience and Healthcare ETF has ranged from $27.70 to $43.01, and now sits 24% of the way up that range.

IBRN news

  • Vandana Singh

    PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.